[EN] 6,6-FUSED HETEROCYCLIC COMPOUNDS AS METTL3 INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES FUSIONNÉS 6,6 EN TANT QU'INHIBITEURS DE METTL3
申请人:[en]858 THERAPEUTICS, INC.
公开号:WO2023129933A2
公开(公告)日:2023-07-06
The present disclosure relates to 6,6-fused heterocyclic compounds and related compounds and their use in treating a disease or condition responsive to modulation or inhibition of METTL3.